Skip to main content

Advertisement

Peer Review reports

From: Postoperative XELOX therapy for patients with curatively resected high-risk stage II and stage III rectal cancer without preoperative chemoradiation: a prospective, multicenter, open-label, single-arm phase II study

Original Submission
19 Jun 2019 Submitted Original manuscript
6 Jul 2019 Author responded Author comments - Tsunekazu Mizushima
Resubmission - Version 2
6 Jul 2019 Submitted Manuscript version 2
29 Jul 2019 Reviewed Reviewer Report - Soichiro Ishihara
4 Aug 2019 Reviewed Reviewer Report - Takayuki Yoshino
12 Aug 2019 Author responded Author comments - Tsunekazu Mizushima
Resubmission - Version 3
12 Aug 2019 Submitted Manuscript version 3
26 Aug 2019 Author responded Author comments - Tsunekazu Mizushima
Resubmission - Version 4
26 Aug 2019 Submitted Manuscript version 4
29 Aug 2019 Author responded Author comments - Tsunekazu Mizushima
Resubmission - Version 5
29 Aug 2019 Submitted Manuscript version 5
Publishing
2 Sep 2019 Editorially accepted
18 Sep 2019 Article published 10.1186/s12885-019-6122-2

You can find further information about peer review here.

Back to article page